¿¬¼ö°­ÁÂ
Á¦8ȸ ÇǺΰúÀǻ縦 À§ÇÑ °Ç¼±Ä¡·á¼¼¹Ì³ª : 2023-04-08

Á¦8ȸ ÇǺΰúÀǻ縦 À§ÇÑ °Ç¼±Ä¡·á¼¼¹Ì³ª : 2023-04-08
±³À°ÀÏÀÚ : 2023-04-08
±³À°Àå¼Ò : »ïÁ¤È£ÅÚ 2Ãþ ¶óº¥´õȦ

±³À°ÁÖÁ¦ : Á¦8ȸ ÇǺΰúÀǻ縦 À§ÇÑ °Ç¼±Ä¡·á¼¼¹Ì³ª

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѰǼ±ÇÐȸ

´ã´çÀÚ : ±èµ¿Çö ±³¼ö
¿¬¶ôó : 031-780-1923

À̸ÞÀÏ : terios92@cha.ac.kr

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04-08 ¶óº¥´õȦ 13:30~13:55 Underlying Mechanisms of Psoriasis Relapse ±èűÕ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-08 ¶óº¥´õȦ 13:55~14:20 Management and therapeutic options of Psoriasis Relapse ¹æöȯ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-08 ¶óº¥´õȦ 14:30~14:55 Increase Adherence To Topical Treatment Á¤°æÀº(Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 04-08 ¶óº¥´õȦ 14:55~15:20 Wise Use of Oral Treatment ¹éÀ¯»ó(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-08 ¶óº¥´õȦ 15:20~15:45 The Phototherapy In Biologic Era Á¤±âÇå(°æÈñÀÇ´ë)

±³À°½Ã°£ 04-08 ¶óº¥´õȦ 16:20~16:40 A patient with hepatitis B virus infection ¹ÚÀºÁÖ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 04-08 ¶óº¥´õȦ 16:40~17:00 A patient with severe itch ±èÁ¤Àº(ÇѾçÀÇ´ë)

±³À°½Ã°£ 04-08 ¶óº¥´õȦ 17:00~17:20 A patient referred for poor response to biologics Á¶¼ºÁø(¼­¿ïÀÇ´ë)

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] 2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ ±³À°ÁÖÁ¦ : 2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,085 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2024-03-09

±³À°ÀÏÀÚ : 2024-03-09 ±³À°Àå¼Ò : (¿Â¶óÀÎ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,055 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialysis Vascular Access) : 2024-03-31

±³À°ÀÏÀÚ : 2024-03-31 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialy

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,097 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ¿Â¶óÀÎ »ýÁß°è ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ ´ã´çÀÚ : °û¼ÖÀÌ ¿¬¶ôó : 02-71

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,184 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,786 , ´ñ±Û¼ö : 0